MedTrace Logo

A Prospective Sample Collection Study Using Non-invasive Methods to Investigate Biomarkers in AD Patients

NCT04699695 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-07-26

No results posted yet for this study

Summary

This is a prospective, multicenter, sample collection study using DermTech's non-invasive skin collection kits to evaluate genomic biomarkers and microbiome information from pediatric and adult subjects with atopic dermatitis(AD). Samples collected will be analyzed to detect gene signatures and microbiome populations associated with AD and sub-populations of AD.

Conditions

Interventions

OTHER

Biologic therapy versus no biologic therapy

Biologic therapy administered per standard of care

Sponsors & Collaborators

  • DermTech

    lead OTHER

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2024-10-15
Completion
2025-04-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04699695 on ClinicalTrials.gov